Acacia Pharma
UK - CambridgePharmaceutical
Focus: Acacia Pharma is a UK-based specialty pharmaceutical company focused on small-molecule therapeutics in psychiatry and critical care sedation. The company operates with a targeted portfolio of FDA-approved products.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Acacia Pharma
AI assessmentNot HiringNo open roles listed right now. Follow Acacia Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Late-stage
5 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Peak11.8yr
Dopamine D2 antagonist with patent protection through 2038, anchoring the psychiatry franchise.
Help build intelligence for Acacia Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.